5th Circuit Mulls Whether Generic Drugmakers Can Change Label Under FDA Rules
NEW ORLEANS — The Fifth Circuit U.S. Court of Appeals held oral arguments on March 6 in an interlocutory appeal of the Taxotere XE "Taxotere" hair loss multidistrict litigation court’s ruling...To view the full article, register now.
Already a subscriber? Click here to view full article